Lineage Cell Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Lineage Cell Therapeutics Inc
CIK #0000876343
EDGAR Form CIK 2011 - 2026
10-K [0000876343]
10-Q [0000876343]
3 [0000876343]
4 [0000876343]
5 [0000876343]
8-K [0000876343]
D [0000876343]
SC 13D [0000876343]
SC 13G [0000876343]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Lineage Cell Therapeutics Inc [2025-04-24]
BlackRock Inc Lineage Cell Therapeutics Inc [2024-11-08]
BlackRock Inc Lineage Cell Therapeutics Inc [2024-10-22]
BlackRock Inc Lineage Cell Therapeutics Inc [2022-07-08]
BlackRock Inc Lineage Cell Therapeutics Inc [2022-02-04]
Biotime Inc Oncocyte Corp [2015-12-31]
Asterias Biotherapeutics Inc Biotime Inc [2013-10-09]
Biotime Inc Asterias Biotherapeutics Inc [2013-10-09]
Form 3/4/5 Subject 2011 - 2026
Jayasuriya Anula
Biotime Inc
Amin Dipti
Russell Angus C
Andrews Deborah J
Bradsher Neal C
Mulroy Michael H
Culley Brian M
Samuel George A III
Howe Jill Ann
Broadwood Partners LP
Broadwood Capital Inc
Bailey Don M
Kingsley Alfred D
Hogge Gary S
Hernandez Alexandra
Cook Kevin Leon
Leavitt Chase C
Farrell Stephen C
Roberts Brandi
Oncocyte Corp
Wirth Edward
Patton Stephana Eilene
Skibsted Russell
West Michael D
Mohanty Aditya P
Redmond Cavan M
Greenbelt Corp /NY
Schlachet David
Segall Judith
Knight James A
Asterias Biotherapeutics Inc
Cartt Stephen LaHue
Peabody Robert
TEW William P PhD
Lichtinger Pedro
Stolz Lesley A
Berger Franklin M
von Eschenbach Andrew C
Nordhoff Henry L
Garcia Peter S
Greenway Partners L P
Burns Arnold I
Cohen Abraham E
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Biotime Inc LCTX
Common Shares
2026-03-12 Buy 15,000 $1.63 24,450
Biotime Inc LCTX
Employee Stock Option (Right to Buy) · derivative
2026-03-05 Grant 900,000 $0.00
Biotime Inc LCTX
Employee Stock Option (Right to Buy) · derivative
2026-03-05 Grant 3,250,000 $0.00
Biotime Inc LCTX
Employee Stock Option (Right to Buy) · derivative
2026-03-05 Grant 1,050,000 $0.00
Biotime Inc LCTX
Restricted Stock Units · derivative
2026-02-11 Option exercise 6,075 $0.00
Biotime Inc LCTX
Common Shares
2026-02-11 Option exercise 6,075
Biotime Inc LCTX
Restricted Stock Units · derivative
2026-02-11 Option exercise 31,250 $0.00
Biotime Inc LCTX
Common Shares
2026-02-11 Option exercise 31,250
Biotime Inc LCTX
Common Shares
2026-02-11 Tax withheld 12,869 $1.80 23,164
Biotime Inc LCTX
Common Shares
2026-02-11 Tax withheld 2,502 $1.80 4,504
Biotime Inc LCTX
Common Shares
2025-12-19 Grant 1,735
Biotime Inc LCTX
Common Shares
2025-12-19 Tax withheld 65 $1.68 109
Biotime Inc LCTX
Common Shares
2025-12-19 Tax withheld 334 $1.68 561
Biotime Inc LCTX
Common Shares
2025-12-19 Grant 8,925
Biotime Inc LCTX
Stock Option (Right to Buy) · derivative
2025-07-01 Grant 75,000 $0.00
Biotime Inc LCTX
Stock Option (Right to Buy) · derivative
2025-07-01 Grant 75,000 $0.00
Biotime Inc LCTX
Stock Option (Right to Buy) · derivative
2025-07-01 Grant 75,000 $0.00
Biotime Inc LCTX
Stock Option (Right to Buy) · derivative
2025-07-01 Grant 75,000 $0.00
Biotime Inc LCTX
OPTION TO PURCHASE COMMON SHARES · derivative
2025-07-01 Grant 75,000 $0.00
Biotime Inc LCTX
Stock Option (Right to Buy) · derivative
2025-07-01 Grant 75,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com